title: The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group.
abstract: Baseline data are presented of the ECAT Angina Pectoris Study. Both plasminogen activator inhibitor and fibrinogen were positively associated with a number of cardiovascular risk factors such as smoking, body mass index, and also with the presence of coronary stenosis. Results indicate a role of the hemostatic system in the progress of coronary arteriosclerosis.
authors.affiliation: Gaubius Laboratory IVVO-TNO, Leiden, The Netherlands.
authors.forename: F
authors.initials: F
authors.lastname: Haverkate
authors.forename: S G
authors.initials: SG
authors.lastname: Thompson
authors.forename: J C
authors.initials: JC
authors.lastname: van de Loo
mesh_terms: D000787:Angina Pectoris / Q000097:blood*; D001780:Blood Coagulation Tests; D003324:Coronary Artery Disease / Q000097:blood*; D003430:Cross-Sectional Studies; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006487:Hemostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D015849:Plasminogen Inactivators / Q000032:analysis; D010978:Platelet Factor 4 / Q000032:analysis; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood; D010959:Tissue Plasminogen Activator / Q000032:analysis; D001620:beta-Thromboglobulin / Q000032:analysis
chemical_list: D015849:Plasminogen Inactivators; D001620:beta-Thromboglobulin; D010978:Platelet Factor 4; D005340:Fibrinogen; D010959:Tissue Plasminogen Activator